LNTH
Lantheus Holdings Inc
NASDAQ: LNTH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$81.17
-2.85% today
Updated 2026-04-29
Market cap
$5.28B
P/E ratio
23.80
P/S ratio
3.43x
EPS (TTM)
$3.41
Dividend yield
—
52W range
$47 – $109
Volume
1.0M
Lantheus Holdings Inc (LNTH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
15.10%
Operating margin
19.10%
ROE
21.40%
ROA
9.28%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $356.29M | $-137.26M | 26.72% | -4.85% | -38.52% |
| 2012 | $288.11M | $-42.00M | 26.10% | -0.26% | -14.58% |
| 2013 | $283.67M | $-61.55M | 27.27% | -6.66% | -21.70% |
| 2014 | $301.60M | $-3.56M | 41.62% | 13.07% | -1.18% |
| 2015 | $293.46M | $-14.75M | 46.18% | 14.49% | -5.02% |
| 2016 | $301.85M | $26.76M | 45.64% | 18.75% | 8.87% |
| 2017 | $331.38M | $123.39M | 48.93% | 15.65% | 37.23% |
| 2018 | $343.37M | $40.52M | 50.93% | 18.78% | 11.80% |
| 2019 | $347.34M | $31.67M | 50.33% | 14.87% | 9.12% |
| 2020 | $339.41M | $-13.47M | 40.88% | -1.24% | -3.97% |
| 2021 | $425.21M | $-71.28M | 44.14% | -14.30% | -16.76% |
| 2022 | $935.06M | $28.07M | 62.21% | 3.87% | 3.00% |
| 2023 | $1.30B | $326.66M | 54.73% | 28.13% | 25.20% |
| 2024 | $1.53B | $312.44M | 64.43% | 29.79% | 20.37% |
| 2025 | $1.54B | $233.56M | 61.10% | 20.16% | 15.15% |